Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies

Brain

Volumn 122, Issue 7, 1999, Pages 1283-1291

  Westland, K W ^a   Pollard, J D ^a   Sander, S ^a   Bonner, J G ^a   Linington, C ^b   McLeod, J G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Activated T cell; Blood brain barrier; Conduction block; Demyelination; Myelin oligodendrocyte glycoprotein

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY; MYELIN; MYELIN BASIC PROTEIN; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HISTOLOGY; MALE; MEMBRANE PERMEABILITY; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NERVE FIBER; NEUROPHYSIOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; THORACIC SPINE;

ANIMALS; ANTIBODIES; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; INJECTIONS, SPINAL; LYMPHOCYTE ACTIVATION; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE BLOCK; NEURAL CONDUCTION; OVALBUMIN; RATS; RATS, INBRED LEW; SPINAL CORD; T-LYMPHOCYTES; TIME FACTORS;

EID: 0032764920     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.7.1283     Document Type: Article

References (22)

1. Andersen O, Lygner PE, Bergstrom T, Andersson M, Vahlne A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993; 240: 417-22.
2. Claudio L, Kress Y, Norton WT, Brosnan CF. Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis. Am J Pathol 1989; 135: 1157-68.
3. Claudio L, Kress Y, Factor J, Brosnan CF. Mechanisms of edema formation in experimental autoimmune encephalomyelitis: the contribution of inflammatory cells. Am J Pathol 1990; 137: 1033-45.
4. Gijbels K, Galardy RE, Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 1994; 94: 2177-82.
5. Harrison BM, Pollard JD. Pattern of Schwann cell remyelination in a spinal cord lesion. Neurosci Lett 1984; 52: 275-80.
6. Hawkins CP, Munro PM, MacKenzie F, Kesselring J, Tofts PS, du Boulay EP, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990; 113: 365-78.
7. Jahnke U, Fischer EH, Alvord EC Jr. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis. Science 1985; 229: 282-4.
8. Kermode AG, Tofts PS, Thompson AJ, MacManus DG, Rudge P, Kendall DP, et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis. An MRI study with gadolinium-DTPA enhancement. Neurology 1990; 40: 229-35.
9. Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, et al. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β, molecule a calcium binding protein of astroglia. J Exp Med 1994; 180: 817-29.
10. Linington C, Webb M, Woodhams PL. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol 1984; 6: 387-96.
11. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988; 130:443-54.
12. Lossinsky AS, Badmajew V, Robson JA, Moretz RG, Wisniewski HM. Sites of egress of inflammatory cells and horseradish peroxidase transport across the blood-brain barrier in a murine model of chronic relapsing experimental allergic encephalomyelitis. Acta Neuropathol (Berl) 1989; 78: 359-71.
13. Miller DH, Rudge P, Johnson G, Kendall BE, Macmanus DG, Moseley IF et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988; 111: 927-39.
14. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, et al. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993; 362: 68-70.
15. Pollard JD. Immune-mediated experimental neuropathies. In: Latov N, Wokke JHJ, Kelly JJ Jr, editors. Immunology and infectious diseases of the peripheral nerves. Cambridge: Cambridge University Press; 1998. p. 36-51.
16. Prineas JW. The neuropathology of multiple sclerosis In: Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology, Vol. 47. Amsterdam: Elsevier; 1985. p. 213-57.
17. Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, Stetler-Stevenson WG. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 1992; 576: 203-7.
18. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985; 1: 1313-5.
19. Spies JM, Westland KW, Bonner JG, Pollard JD. Intraneural activated T cells cause focal breakdown of the blood-nerve barrier. Brain 1995; 118: 857-68.
20. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linnington C. Animal models. Ann Neurol 1994; 36 Suppl: S47-53.
21. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
22. Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM-1 ganglioside-like structure. J Exp Med 1993; 178: 1771-5.